Institute for Integrative Therapies Press Releases - EIN Presswire

Published on August 11, 2026 - 18:57 GMT

Institute for Integrative Therapies Selected as Clinical Trial Site for COMPASS Pathways’ Psilocybin Treatment for PTSD

Minnesota research center expands its psychedelic medicine research program into post-traumatic stress disorder EDEN PRAIRIE, MN, UNITED STATES, August 11, 2026 /⁨EINPresswire.com⁩/ -- The Institute for Integrative Therapies (IIT) announced today that it …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on December 16, 2025 - 17:42 GMT

IIT Selected as a Clinical Trial Site for ataiBeckley’s DMT Study for Treatment-Resistant Depression

EDEN PRAIRIE, MN, UNITED STATES, December 16, 2025 /⁨EINPresswire.com⁩/ -- The Institute for Integrative Therapies (IIT), one of the Midwest’s leading centers for psychedelic medicine and clinical research, today announced its selection as a clinical trial …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on November 20, 2025 - 19:37 GMT

Institute for Integrative Therapies Selected as a Clinical Trial Site for Cybin’s EMBRACE and EXTEND Psilocin Studies

EDEN PRAIRIE, MN, UNITED STATES, November 20, 2025 /⁨EINPresswire.com⁩/ -- The Institute for Integrative Therapies (IIT), Minnesota’s leading psychedelic medicine clinic, is proud to announce its official selection as a clinical trial site for Cybin’s …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on July 25, 2025 - 15:43 GMT

Institute for Integrative Therapies Launches Psilocybin Depression Study in Collaboration with COMPASS Pathways

IIT launches psilocybin depression trial as part of COMPASS Pathways’ global Phase 3 study on treatment-resistant depression. EDEN PRAIRIE, MN, UNITED STATES, July 25, 2025 /⁨EINPresswire.com⁩/ -- Institute for Integrative Therapies Launches Psilocybin …

Distribution channels: Healthcare & Pharmaceuticals Industry ...